GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » Long-Term Debt

Itonis (Itonis) Long-Term Debt : $0.00 Mil (As of Feb. 2008)


View and export this data going back to 2007. Start your Free Trial

What is Itonis Long-Term Debt?

Itonis's Long-Term Debt for the quarter that ended in Feb. 2008 was $0.00 Mil.


Itonis Long-Term Debt Historical Data

The historical data trend for Itonis's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis Long-Term Debt Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
Long-Term Debt
- - -

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Itonis  (OTCPK:ITNS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Itonis Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Itonis's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Itonis (Itonis) Business Description

Traded in Other Exchanges
N/A
Address
22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines